LONDON (AP) — AstraZeneca board rejects sweetened takeover offer from Pfizer. Recommended Stories Walmart settles with DOJ over alleged unlawful opioid dispensing OxyContin maker Purdue Pharma set to dissolve after judge approves sentence Rite Aid closes all of its stores nationwide Print subscriber? Click here to login/register your account Digital subscriber? Click here to login/register your account. Trusted reporting.Unlimited access. Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism. Get Unlimited Access › Already a member? Log in Cancel anytime.